 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || Victoza (liraglutide) / Novo Nordisk, liraglutide injection (RD12014) / HEC Pharm
P1 data, PK/PD data, Journal: A phase I study comparing the pharmacokinetics of the biosimilar (RD12014) with liraglutide (Victoza®) in healthy Chinese male subjects. (Pubmed Central) - Oct 21, 2022
This study demonstrated pharmacokinetic similarity of RD12014 to Victoza® in healthy Chinese male subjects. Safety and immunogenicity profiles were comparable between the two groups.
- || RD12014 (liraglutide biosimilar) / HEC Pharm
New P1 trial: A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza (clinicaltrials.gov) - Mar 23, 2022
P1, N=50, Completed, Sponsor: Sunshine Lake Pharma Co., Ltd.